cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
YCBD.PRA was delisted on the 5th of May, 2025.
7 hedge funds and large institutions have $658K invested in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
1% less capital invested
Capital invested by funds: $663K → $658K (-$5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$31.9K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
+$14.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25.4K |
YCBD.PRA Hedge Fund Activity: Q3 2022 in Review
7 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) for Q3 2022, worth a combined $658K — down 0.75% from $663K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new YCBD.PRA positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $31.9K. The largest seller was Susquehanna International Group, cutting an estimated $25.4K.
- 7 institutional investors held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) as of Q3 2022, up from 6 in Q2 2022.
- Funds reported $658K of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock stock for Q3 2022, down 0.75% quarter-over-quarter.
- 1 fund opened new cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock positions in Q3 2022 and 0 closed out, a net change of +1 holder.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock buyer in Q3 2022 was UBS Group, an estimated $31.9K added.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock seller in Q3 2022 was Susquehanna International Group, an estimated $25.4K sold.
Based on aggregated 13F filings for Q3 2022.